ClinicalTrials.gg
Drug

Natalizumab clinical trials

Also written Tysabri, BG00002 and Antegren.

studies test it
58
open now
2
in phase 3
13
first study started
2001

How each study uses Natalizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Natalizumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Nov 2004 · TYSABRI · BLA 125104 (FDA, Drugs@FDA)
European Union
27 Jun 2006 · Tysabri · EMEA/H/C/000603 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Natalizumab
42
BG00002 (natalizumab)
5
Tysabri (natalizumab)
2

Brand

Tysabri
38

Development codes

BG00002
15
AN100226
1

Other names

Antegren
2

Biosimilars

Tyruko
1

Studies by the year they started

58 studies that test it; most in 2010 (6)

Studies that test Natalizumab, by start year
YearStudies
20012
20025
20032
20043
20063
20071
20085
20092
20106
20113
20122
20132
20145
20152
20163
20171
20182
20192
20223
20232
20241
20261

Who runs them

Industry 39 · Other 19

Biogen (39) · The Cleveland Clinic (1) · Washington University School of Medicine (1) · State University of New York at Buffalo (1) · King's College London (1) · John Levine (1) · Dana-Farber Cancer Institute (1) · Amsterdam UMC, location VUmc (1)

Often tested with

Tested in the same studies.

Glatiramer (2) · Interferon beta-1a (2) · Methylprednisolone (2) · Motixafortide (1) · Fingolimod (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test Natalizumab.

Studies

Open first, then newest update. How each study uses Natalizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 58

See all 58 studies that test Natalizumab →

As the comparator · 1 — what is tested is compared with Natalizumab

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Natalizumab · ClinicalTrials.gg INT006576

  • MeSH (NLM) D000069442NatalizumabConfirmed ClinicalTrials.gov, Wikidata
  • UNII (FDA) 3JB47N2Q2PNATALIZUMABConfirmed FDA, Wikidata
  • RxNorm 354770Confirmed FDA, Wikidata
  • Wikidata Q386119natalizumabConfirmed FDA, Wikidata
  • NCI Thesaurus C77862NatalizumabOne source FDA
  • DrugBank DB00108One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.